Altitude Crest Partners »

Ambrx Biopharma shares owned by Altitude Crest Partners

Quarter-by-quarter ownership of Ambrx Biopharma shares owned by Altitude Crest Partners from 13F filings

Historical chart of Altitude Crest Partners investment in Ambrx Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Ambrx Biopharma held by Altitude Crest Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ambrx Biopharma by Altitude Crest Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $614k 43k 14.24

More positions owned by Altitude Crest Partners

Legend Biotech Corp Sponsored Ads (LEGN)
Bridgebio Pharma (BBIO)
Danaher Corporation (DHR)
Argenx Se Sponsored Adr (ARGX)
BioMarin Pharmaceutical (BMRN)
Apellis Pharmaceuticals (APLS)
Roivant Sciences SHS (ROIV)
Kiniksa Pharmaceuticals Com Cl A (KNSA)
EXACT Sciences Corporation (EXAS)
Aligos Therapeutics (ALGS)
Ambrx Biopharma
Surrozen *w Exp 08/01/203 (SRZNW)

View all positions for Altitude Crest Partners

Top funds holding Ambrx Biopharma

Federated Investors
Alliancebernstein
Altitude Crest Partners
Virtu Financial

View all funds holding Ambrx Biopharma